4.7 Article

Rates and Determinants of 5-Year Outcomes After Atrial Fibrillation-Related Stroke A Population Study

Journal

STROKE
Volume 46, Issue 12, Pages 3488-3493

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/STROKEAHA.115.011139

Keywords

atrial fibrillation; nursing homes; rehabilitation; stroke; survival

Funding

  1. Bayer Newman Fellowship in Stroke Prevention in Atrial Fibrillation
  2. Irish Heart Foundation
  3. Health Research Board
  4. Irish Health Services Executive, National Lottery of Ireland and Servier (North Dublin Population Stroke Study)
  5. Bristol Meyer Squibb
  6. Bayer
  7. Boehringer Ingelheim
  8. Daiichi Sankyo
  9. Health Research Board of Ireland

Ask authors/readers for more resources

Background and Purpose-Demographic trends in atrial fibrillation (AF) incidence may yield a substantial rise in the societal burden of AF-related stroke (AF-stroke). Accurate population-wide outcome data are essential to inform health service planning to improve AF-stroke prevention, and provision of rehabilitation, nursing home, and community supports for AF-stroke survivors. Methods-We investigated rates and determinants of 5-year fatality, stroke recurrence, functional outcomes, and prescribing of secondary prevention medications in AF-stroke in the North Dublin Population Stroke Study. Ascertainment included hot and cold pursuit using multiple overlapping sources. Survival analysis was performed using lifetables and Kaplan-Meier survival curves, and Cox proportional hazard modeling was performed to identify predictors of death and recurrent stroke. Results-Five hundred sixty-eight patients with new stroke were identified, including 177 (31.2%) AF-stroke. At 5 years, 39.2% (confidence interval, 31.5-46.8) of ischemic AF-stroke patients were alive. Congestive heart failure, hypertension, age <65, 65-74 years, and >= 75 years, diabetes mellitus, prior stroke, transient ischemic attack or thromboembolism, vascular disease and female sex (CHA(2)DS(2)-VASc) score (hazard ratio [HR], 1.34; P<0.001), CHADS(2) score (HR 1.42, P=0.004), National Institute of Health Stroke Scale (HR, 1.09; P<0.0001), and subtherapeutic international normalized ratio (<2.0) at stroke onset (HR, 3.29; P=0.003) were independently associated with 5-year fatality, whereas warfarin (HR, 0.40; P=0.001) and statin use after index stroke (HR, 0.52; P=0.005) were associated with improved survival. The 5-year recurrence rate after ischemic AF-stroke was 21.5% (confidence interval, 14.5-31.3). Trends toward greater risk of recurrence were observed for persistent AF (HR, 3.09; P=0.07) and CHA(2)DS(2)-VASc score (HR, 1.34; P=0.07). Nursing home care was needed for 25.9% of patients. Conclusions-AF-stroke is associated with considerable long-term morbidity, fatality, stroke recurrence, and nursing home requirement. Adequately resourced national AF strategies to improve AF detection and prevention are needed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available